1. Home
  2. CYBN vs DLNG Comparison

CYBN vs DLNG Comparison

Compare CYBN & DLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • DLNG
  • Stock Information
  • Founded
  • CYBN 2019
  • DLNG 2013
  • Country
  • CYBN Canada
  • DLNG Greece
  • Employees
  • CYBN N/A
  • DLNG N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • DLNG Marine Transportation
  • Sector
  • CYBN Health Care
  • DLNG Consumer Discretionary
  • Exchange
  • CYBN Nasdaq
  • DLNG Nasdaq
  • Market Cap
  • CYBN 147.4M
  • DLNG 127.5M
  • IPO Year
  • CYBN N/A
  • DLNG 2013
  • Fundamental
  • Price
  • CYBN $6.34
  • DLNG $3.55
  • Analyst Decision
  • CYBN Strong Buy
  • DLNG
  • Analyst Count
  • CYBN 3
  • DLNG 0
  • Target Price
  • CYBN $85.00
  • DLNG N/A
  • AVG Volume (30 Days)
  • CYBN 1.0M
  • DLNG 51.2K
  • Earning Date
  • CYBN 11-17-2025
  • DLNG 11-21-2025
  • Dividend Yield
  • CYBN N/A
  • DLNG 5.38%
  • EPS Growth
  • CYBN N/A
  • DLNG 90.14
  • EPS
  • CYBN N/A
  • DLNG 1.14
  • Revenue
  • CYBN N/A
  • DLNG $158,453,000.00
  • Revenue This Year
  • CYBN N/A
  • DLNG N/A
  • Revenue Next Year
  • CYBN N/A
  • DLNG $0.37
  • P/E Ratio
  • CYBN N/A
  • DLNG $3.17
  • Revenue Growth
  • CYBN N/A
  • DLNG N/A
  • 52 Week Low
  • CYBN $4.81
  • DLNG $3.18
  • 52 Week High
  • CYBN $13.88
  • DLNG $5.65
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 48.10
  • DLNG 47.84
  • Support Level
  • CYBN $6.86
  • DLNG $3.51
  • Resistance Level
  • CYBN $8.00
  • DLNG $3.65
  • Average True Range (ATR)
  • CYBN 0.48
  • DLNG 0.11
  • MACD
  • CYBN 0.06
  • DLNG 0.01
  • Stochastic Oscillator
  • CYBN 27.48
  • DLNG 40.00

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About DLNG Dynagas LNG Partners LP Common Units

Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.

Share on Social Networks: